Phase I/II Results of a Multicenter Trial of Perifosine (KRX-0401) + Bortezomib in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma Who Were Previously Relapsed from or Refractory to Bortezomib
Autor: | Richardson, Paul, Wolf, Jeffrey *, Jakubowiak, Andrzej, Zonder, Jeffrey, Lonial, Sagar, Irwin, David H *, Densmore, John, Krishnan, Amrita, Raje, Noopur *, Bar, Michael H., Allerton, Jeffrey P., Schlossman, Robert *, Ghobrial, Irene M., Munshi, Nikhil C., Martin, Thomas, Laubach, Jacob *, Colson, Kathy *, Dean, Sarah *, Tocco, Deanna *, Steinfield, Elizabeth *, Kendall, Tara *, O'Riley, Kimberly *, Hideshima, Teru, Sportelli, Peter *, Gardner, Lesa *, Anderson, Kenneth C. |
---|---|
Zdroj: | In Blood 16 November 2008 112(11):870-870 |
Databáze: | ScienceDirect |
Externí odkaz: |